JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.
Silvergate Capital Q4 Adj. EPS $0.48 Misses $0.81 Estimate
Silvergate Capital (NYSE:SI) reported quarterly earnings of $0.48 per share which missed the analyst consensus estimate of $0.81 by 40.74 percent. This is a 27.27 percent decrease over earnings of $0.66 per share from
